GSA CAPITAL PARTNERS LLP - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q1 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2023$1,097
+965.0%
1,841,078
+931.5%
0.09%
+840.0%
Q2 2023$103
-18.9%
178,489
-1.0%
0.01%
-23.1%
Q1 2023$127
-91.3%
180,363
-72.0%
0.01%
-92.8%
Q4 2022$1,458
-99.2%
645,035
+988.0%
0.18%
+624.0%
Q3 2022$190,000
+23.4%
59,287
+46.7%
0.02%
+8.7%
Q2 2022$154,000
+8.5%
40,426
+284.0%
0.02%
+27.8%
Q4 2021$142,000
-65.0%
10,527
-53.4%
0.02%
-56.1%
Q3 2021$406,000
-73.0%
22,583
-74.2%
0.04%
-75.7%
Q2 2021$1,504,000
+203.2%
87,659
+193.1%
0.17%
+103.6%
Q3 2020$496,000
-48.3%
29,909
+90.1%
0.08%
+56.6%
Q3 2018$959,000
+18.4%
15,737
-5.1%
0.05%
+32.5%
Q2 2018$810,000
-4.7%
16,586
+16.5%
0.04%
-23.1%
Q4 2017$850,000
-41.5%
14,236
-76.5%
0.05%
-47.5%
Q3 2017$1,454,000
+372.1%
60,598
+141.4%
0.10%
+450.0%
Q4 2016$308,000
-16.1%
25,105
-6.0%
0.02%
-21.7%
Q1 2016$367,000
-38.5%
26,713
-24.6%
0.02%
-20.7%
Q4 2015$597,000
+20.4%
35,416
-21.8%
0.03%
+20.8%
Q3 2015$496,000
-66.3%
45,292
-61.5%
0.02%
-57.1%
Q2 2015$1,471,000
+7.7%
117,578
-5.3%
0.06%
+3.7%
Q1 2015$1,366,000
+120.7%
124,206
+211.0%
0.05%
+25.6%
Q4 2014$619,000
-16.5%
39,935
-34.9%
0.04%
+10.3%
Q3 2014$741,000
+152.9%
61,361
+168.9%
0.04%
+200.0%
Q2 2014$293,00022,8160.01%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2022
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 508,000$6,132,0001.80%
Bodri Capital Management, LLC 250,000$3,018,0001.46%
Granahan Investment Management 3,442,980$41,557,0001.28%
TIRSCHWELL & LOEWY INC 603,441$7,284,0001.22%
NEA Management Company, LLC 1,825,600$22,035,0001.12%
Cormorant Asset Management, LP 450,000$5,432,0001.12%
HARVEY CAPITAL MANAGEMENT INC 221,750$2,676,0001.05%
Cheyne Capital Management (UK) LLP 229,577$2,772,0000.99%
Artal Group S.A. 1,650,000$19,916,0000.73%
FIC CAPITAL INC 147,293$1,778,0000.71%
View complete list of NEKTAR THERAPEUTICS shareholders